Figure 6
From: Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles

Pharmacokinetics of Nano-X-111In in mice.
BALB/c mice (n = 8) were intravenously injected with 20 μCi of Nano-X-111In. The concentration of Nano-X-111In was measured by the anti-PEG bioparticle-based ELISA (○). The radioactivity of Nano-X-111In in the serum sample was directly measured by a gamma counter (●). Data represents mean ± SD. Statistical analysis was performed by independent t-test (P = 0.9994). ns, no significant difference.